These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23528807)

  • 1. The current and potential impact of genetics and genomics on neuropsychopharmacology.
    Harrison PJ
    Eur Neuropsychopharmacol; 2015 May; 25(5):671-81. PubMed ID: 23528807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics and genomics in neuropsychopharmacology: the impact on drug discovery and development.
    Hurko O
    Eur Neuropsychopharmacol; 2001 Dec; 11(6):491-9. PubMed ID: 11704426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics, informatics, and individual drug therapy in psychiatry: past, present and future.
    Preskorn SH
    J Psychopharmacol; 2006 Jul; 20(4 Suppl):85-94. PubMed ID: 16785276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Status of and perspectives on psychiatric genomic medicine].
    Mors NP; Børglum AD
    Ugeskr Laeger; 2005 May; 167(20):2191-3. PubMed ID: 15987082
    [No Abstract]   [Full Text] [Related]  

  • 5. The promise and reality of pharmacogenetics in psychiatry.
    Zandi PP; Judy JT
    Clin Lab Med; 2010 Dec; 30(4):931-74. PubMed ID: 20832660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of serendipity in the discovery of the clinical effects of psychotropic drugs: beyond of the myth.
    López-Muñoz F; Baumeister AA; Hawkins MF; Alamo C
    Actas Esp Psiquiatr; 2012; 40(1):34-42. PubMed ID: 22344494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive perception of pharmacogenetic testing for psychotropic medications.
    Lanktree MB; Zai G; Vanderbeek LE; Giuffra DE; Smithson DS; Kipp LB; Dalseg TR; Speechley M; Kennedy JL
    Hum Psychopharmacol; 2014 May; 29(3):287-91. PubMed ID: 24604560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomics and epigenomics in novel schizophrenia drug discovery: translating animal models to clinical research and back.
    Bosia M; Pigoni A; Cavallaro R
    Expert Opin Drug Discov; 2015 Feb; 10(2):125-39. PubMed ID: 25345474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders.
    Millan MJ; Goodwin GM; Meyer-Lindenberg A; Ove Ögren S
    Eur Neuropsychopharmacol; 2015 May; 25(5):599-656. PubMed ID: 25836356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Back to the future of psychopharmacology: A perspective on animal models in drug discovery.
    Hendriksen H; Groenink L
    Eur J Pharmacol; 2015 Jul; 759():30-41. PubMed ID: 25814259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric pharmacogenomics in pediatric psychopharmacology.
    Wall CA; Croarkin PE; Swintak C; Koplin BA
    Child Adolesc Psychiatr Clin N Am; 2012 Oct; 21(4):773-88. PubMed ID: 23040901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Present and future of developmental neuropsychopharmacology.
    Arango C
    Eur Neuropsychopharmacol; 2015 May; 25(5):703-12. PubMed ID: 25432076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
    Arranz MJ; de Leon J
    Mol Psychiatry; 2007 Aug; 12(8):707-47. PubMed ID: 17549063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.
    Miyamoto S; Miyake N; Jarskog LF; Fleischhacker WW; Lieberman JA
    Mol Psychiatry; 2012 Dec; 17(12):1206-27. PubMed ID: 22584864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The promise of psychiatric pharmacogenomics.
    Hamilton SP
    Biol Psychiatry; 2015 Jan; 77(1):29-35. PubMed ID: 25483343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics of psychiatric disorders.
    Pickar D; Rubinow K
    Trends Pharmacol Sci; 2001 Feb; 22(2):75-83. PubMed ID: 11166851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychopharmacology and the genetics of schizophrenia: a history of the diagnosis of schizophrenia.
    Ban TA
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Aug; 28(5):753-62. PubMed ID: 15363601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics. Promise and potential in child and adolescent psychiatry.
    Anderson GM; Cook EH
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):23-42, viii. PubMed ID: 10674189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How pharmacogenomics (PG) are changing practice: implications for prescribers, their patients, and the healthcare system (PG series part I).
    Preskorn SH; Hatt CR
    J Psychiatr Pract; 2013 Mar; 19(2):142-9. PubMed ID: 23507814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics and psychopharmacology: prospects for individualized treatment.
    Nnadi CU; Goldberg JF; Malhotra AK
    Essent Psychopharmacol; 2005; 6(4):193-208. PubMed ID: 16041916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.